2021
DOI: 10.1016/j.addbeh.2021.106939
|View full text |Cite
|
Sign up to set email alerts
|

Examining e-cigarette perspectives before and after the EVALI peak in cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 16 publications
1
3
0
Order By: Relevance
“…However, the timing of those lower ratings corresponds to intense negative media coverage in 2019 associated with E-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI; 31, 32). Observing lower ratings after EVALI made headlines is consistent with findings from a study that compared perceptions of e-cigarettes from samples before and after EVALI made headlines (19) and a study that reports on less interests in using e-cigarettes among smokers who had heard about EVALI (33). Ratings across the studies appear to have rebounded after it was demonstrated that EVALI was primarily linked to vitamin E acetate added to certain THC containing vapor products rather than to nicotine ENDS products (34).…”
Section: Discussionsupporting
confidence: 85%
See 1 more Smart Citation
“…However, the timing of those lower ratings corresponds to intense negative media coverage in 2019 associated with E-Cigarette, or Vaping, Product Use Associated Lung Injury (EVALI; 31, 32). Observing lower ratings after EVALI made headlines is consistent with findings from a study that compared perceptions of e-cigarettes from samples before and after EVALI made headlines (19) and a study that reports on less interests in using e-cigarettes among smokers who had heard about EVALI (33). Ratings across the studies appear to have rebounded after it was demonstrated that EVALI was primarily linked to vitamin E acetate added to certain THC containing vapor products rather than to nicotine ENDS products (34).…”
Section: Discussionsupporting
confidence: 85%
“…As part of its guidance, FDA recommends that ENDS manufacturers provide population-level estimates of behavioral intentions and product appeal of their products among both tobacco users and nonusers. Although there are several published reports in the tobacco literature about behavioral intentions (11)(12)(13)(14)(15)(16)(17) and product appeal (18)(19)(20)(21)(22)(23)(24), those reports do not provide population-level estimates that are critical to evaluating the impact of products on public health. The present work addresses this data gap.…”
Section: Resumementioning
confidence: 99%
“…This study is limited by a small sample, and although not uncommon for qualitative research, generalizability may be limited. Data were collected in fall 2018, before widespread media attention about e-cigarette or vaping product use-associated lung injury (EVALI), which could alter smokers' perceptions of ENDS [58]. By nature of our inclusion criteria (current dual users), people who already quit smoking by using ENDS were excluded.…”
Section: Discussionmentioning
confidence: 99%
“…These results indicate that smoking-related beliefs and behaviors continue to have a major role in the Hispanic community that need to be further examined according to the risks correlated by different ethnic subgroups. Given the increasing evidence linking e-cigarettes to cancer outcomes, as well e-cigarette or vaping product use-associated lung injury (EVALI), significant attention should be paid to reducing e-cigarette initiation among Hispanics, in particular, young adults [ 40 , 41 , 42 ]. While the prevalence of smoking at large continues to decline, it is an important public health responsibility for future studies, medical professionals, and health interventions to acknowledge these differences among Hispanic subpopulations.…”
Section: Discussionmentioning
confidence: 99%